- Home
- NRIX vs CDLR Comparison
NRIX vs CDLR Comparison
Compare NRIX & CDLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRIX | CDLR |
|---|---|---|
| Founded | 2009 | 2008 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.5B |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | NRIX | CDLR |
|---|---|---|
| Price | $23.40 | $21.29 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $33.93 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 50.6K |
| Earning Date | 10-08-2026 | 11-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $76,987,000.00 | N/A |
| Revenue This Year | $799.42 | $57.70 |
| Revenue Next Year | N/A | $37.69 |
| P/E Ratio | ★ N/A | $7.39 |
| Revenue Growth | ★ 99.31 | N/A |
| 52 Week Low | $9.00 | $15.37 |
| 52 Week High | $28.23 | $30.01 |
Technical Indicators
Market Signals| Indicator | NRIX | CDLR |
|---|---|---|
| Relative Strength Index (RSI) | 41.91 | 30.13 |
| Support Level | $22.56 | $20.81 |
| Resistance Level | $24.98 | $23.64 |
| Average True Range (ATR) | 0.92 | 0.39 |
| MACD | -0.18 | -0.47 |
| Stochastic Oscillator | 37.56 | 0.88 |
Price Performance
Historical ComparisonAbout NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
About CDLR Cadeler AS
Cadeler AS is an offshore wind installation vessel contractor. It currently operates various offshore jack-up wind installation vessels, with new builds on order. The Group operates within the market for the transportation and installation of offshore wind turbine generators (WTGs) and their foundations. In addition to wind farm installation, its vessels can perform maintenance, decommissioning, and other general construction tasks within the offshore industry. Cadler's customer base consists of offshore wind farm developers, original equipment manufacturers, and various offshore contractors. Geographically, the Group generates maximum revenue from the United States and the rest from the United Kingdom, Taiwan, Germany, Denmark, Poland, and other regions.